covid patent

<font size="4" face="Times New Roman">=</font><div><font face="Times New Roman" size="4">neglected? orig plandemic BS</font></div><div><font face="Times New Roman" size="4">
</font></div><div><font face="Times New Roman" size="4">=</font></div><div><div style="font-size: small; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">=</font></div><div style="font-size: small; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">&nbsp;8 22</font></div><div style="font-size: small; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">
</font></div><div style="font-size: small; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman"><a href="https://www.alternet.org/2022/08/moderna-sues-two-competitors-vaccine/" style="text-decoration-line: none; font-weight: bold; color: rgb(0, 51, 153); outline: none;">https://www.alternet.org/2022/08/moderna-sues-two-competitors-vaccine/</a></font></div><div style="font-size: small; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">=</font></div></div><div><div style="font-size: small; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">=</font></div><div style="font-size: small; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">
</font></div><div style="font-size: small; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman"><a href="https://www.nature.com/articles/d41586-021-02483-w" style="text-decoration-line: none; font-weight: bold; color: rgb(0, 51, 153); outline: none;">https://www.nature.com/articles/d41586-021-02483-w</a></font></div><div style="font-size: small; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">NO LNx</font></div><div style="font-size: small; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman" /><div><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman">
</font></font></font></font></font></font></font></div><div>14 September 2021</div><div>Correction 22 October 2021</div><div><b>The tangled history of mRNA vaccines</b></div><div>Hundreds of scientists had worked on mRNA vaccines for decades before the coronavirus pandemic brought a breakthrough.</div><div>Elie Dolgin</div><div>
</div><div>Illustration that shows the mRNA code used in the Pfizer–BioNTech vaccine, with a syringe containing a lipid nanoparticle.</div><div>The RNA sequence used in the COVID-19 vaccine developed by Pfizer and BioNTech (? is a modified form of the uridine nucleotide, U).Credit: Nik Spencer/Nature</div><div>
</div><div><span style="background-color: rgb(255, 255, 102);">In late 1987, Robert Malone performed a landmark experiment. He mixed strands of messenger RNA with droplets of fat, to create a kind of molecular stew. Human cells bathed in this genetic gumbo absorbed the mRNA, and began producing proteins from it1.</span></div><div><span style="background-color: rgb(255, 255, 102);">
</span></div><div><span style="background-color: rgb(255, 255, 102);">Realizing that this discovery might have far-reaching potential in medicine, Malone, a graduate student at the Salk Institute for Biological Studies in La Jolla, California, later jotted down some notes, which he signed and dated.</span>&nbsp;<b>If cells could create proteins from mRNA delivered into them, he wrote on 11 January 1988, it might be possible to “treat RNA as a drug”. Another member of the Salk lab signed the notes, too, for posterity. Later that year, Malone’s experiments showed that frog embryos absorbed such mRNA2. It was the first time anyone had used fatty droplets to ease mRNA’s passage into a living organism.</b></div><div>
</div><div><span style="background-color: rgb(255, 255, 51);">Those experiments were a stepping stone towards two of the most important and profitable vaccines in history: the mRNA-based COVID-19 vaccines given to hundreds of millions of people around the world. Global sales of these are expected to top US$50 billion in 2021 alone.</span></div><div>
</div><div><b>But the path to success was not direct. For many years after Malone’s experiments, which themselves had drawn on the work of other researchers, mRNA was seen as too unstable and expensive to be used as a drug or a vaccine. Dozens of academic labs and companies worked on the idea, struggling with finding the right formula of fats and nucleic acids — the building blocks of mRNA vaccines.</b></div><div>
</div><div>Today’s mRNA jabs have innovations that were invented years after Malone’s time in the lab, including chemically modified RNA and different types of fat bubble to ferry them into cells (see ‘Inside an mRNA COVID vaccine’). Still, Malone, who calls himself the “inventor of mRNA vaccines”, thinks his work hasn’t been given enough credit. “I’ve been written out of history,” he told Nature.</div><div>
</div><div>Inside an mRNA COVID vaccine: infographic that shows the innovations used in the mRNA and nanoparticle of the vaccine.</div><div>Nik Spencer/Nature; Adapted from M. D. Buschmann et al. Vaccines 9, 65 (2021)</div><div>
</div><div><b>The debate over who deserves credit for pioneering the technology is heating up as awards start rolling out&nbsp;</b>— and the speculation is getting more intense in advance of the Nobel prize announcements next month. But formal prizes restricted to only a few scientists will fail to recognize the many contributors to mRNA’s medical development. In reality, the path to mRNA vaccines drew on the work of hundreds of researchers over more than 30 years.</div><div>
</div><div><b>The story illuminates the way that many scientific discoveries become life-changing innovations: with decades of dead ends, rejections and battles over potential profits, but also generosity, curiosity and dogged persistence against scepticism and doubt. “It’s a long series of steps,</b>” says Paul Krieg, a developmental biologist at the University of Arizona in Tucson, who made his own contribution in the mid-1980s,&nbsp;<b>“and you never know what’s going to be useful”.</b></div><div>
</div><div>The beginnings of mRNA</div><div>Malone’s experiments didn’t come out of the blue. As far back as 1978, scientists had used fatty membrane structures called liposomes to transport mRNA into mouse3 and human4 cells to induce protein expression. The liposomes packaged and protected the mRNA and then fused with cell membranes to deliver the genetic material into cells. These experiments themselves built on years of work with liposomes and with mRNA; both were discovered in the 1960s (see ‘The history of mRNA vaccines’).</div><div>
</div><div>The history of mRNA vaccines: A timeline that shows the key scientific innovations in the development of mRNA vaccines.</div><div>Nik Spencer/Nature; Adapted from U. Sahin et al. Nature Rev. Drug Discov. 13, 759–780 (2014) and X. Hou et al. Nature Rev. Mater. https://doi.org/gmjsn5 (2021).</div><div>
</div><div><span style="background-color: rgb(255, 255, 102);">Back then, however, few researchers were thinking about mRNA as a medical product — not least because there was not yet a way to manufacture the genetic material in a laboratory. Instead, they hoped to use it to interrogate basic molecular processes. Most scientists repurposed mRNA from rabbit blood, cultured mouse cells or some other animal source.</span></div><div>
</div><div><span style="background-color: rgb(255, 255, 102);">That changed in 1984, when Krieg and other members of a team led by developmental biologist Douglas Melton and molecular biologists Tom Maniatis and Michael Green at Harvard University in Cambridge, Massachusetts, used an RNA-synthesis enzyme (taken from a virus) and other tools to produce biologically active mRNA in the lab5 — a method that, at its core, remains in use today.</span><b><span style="background-color: rgb(255, 255, 102);">&nbsp;</span>Krieg then injected the lab-made mRNA into frog eggs, and showed that it worked just like the real thing6.</b></div><div>
</div><div>B<b>oth Melton and Krieg say they saw synthetic mRNA mainly as a research tool for studying gene function and activity<span style="background-color: rgb(255, 255, 102);">.&nbsp;</span></b><span style="background-color: rgb(255, 255, 102);">In 1987, after Melton found that the mRNA could be used both to activate and to prevent protein production, he helped to form a company called Oligogen (later renamed&nbsp;<b>Gilead Sciences&nbsp;</b>in Foster City, California) t</span>o explore ways to use synthetic RNA to block the expression of target genes — with an eye to treating disease. Vaccines weren’t on the mind of anyone in his lab, or their collaborators.</div><div>
</div><div>Diptych of portraits of Paul Krieg and Douglas Melton</div><div>Paul Krieg (left) and Douglas Melton (right), who worked on ways to synthesize mRNA in the laboratory.Credit: University of Arizona; Kevin Wolf/AP Images for HHMI</div><div>
</div><div>“RNA in general had a reputation for unbelievable instability,” says Krieg. “Everything around RNA was cloaked in caution.” That might explain why Harvard’s technology-development office elected not to patent the group’s RNA-synthesis approach. Instead, the Harvard researchers simply gave their reagents to Promega Corporation, a lab-supplies company in Madison, Wisconsin, which made the RNA-synthesis tools available to researchers. They received modest royalties and a case of Veuve Clicquot Champagne in return.</div><div>
</div><div>Patent disputes</div><div>Years later, Malone followed the Harvard team’s tactics to synthesize mRNA for his experiments. But he added a new kind of liposome, one that carried a positive charge, which enhanced the material’s ability to engage with the negatively charged backbone of mRNA. These liposomes were developed by Philip Felgner, a biochemist who now leads the Vaccine Research and Development Center at the&nbsp;<b>University of California, Irvine.</b></div><div>
</div><div>Diptych of portraits of Philip Felgner and Robert Malone</div><div>Philip Felgner (left) and Robert Malone.Credit: Steve Zylius/UCI; Robert Malone</div><div>
</div><div><span style="background-color: rgb(255, 255, 102);">Despite his success using the liposomes to deliver mRNA into human cells and frog embryos, Malone never earned a PhD. He fell out with his supervisor, Salk gene-therapy researcher Inder Verma and, in 1989, left graduate studies early to work for Felgner at Vical, a recently formed start-up in San Diego, California. There, they and collaborators at the University of Wisconsin–Madison showed that the lipid–mRNA complexes could spur protein production in mice7</span>. (<b>Malone and his Vical coworkers also explored using mRNA for vaccines: their early patent filings describe injecting mRNA coding for HIV proteins into mice, and observing some protection against infection, although not the production of specific immune cells or molecules; this work was never published in a peer-reviewed journal</b>).</div><div>
</div><div>[An excerpt from Robert Malone’s lab notebooks, describing the 1989 synthesis of mRNA for injection into mice</div><div>
</div><div>
</div><div><b>Then things got messy. Both Vical (with the University of Wisconsin) and the Salk began filing for patents in March 1989. But the Salk soon abandoned its patent claim, and in 1990, Verma joined Vical’s advisory board.</b></div><div>
</div><div>Malone contends that Verma and Vical struck a back-room deal so that the relevant intellectual property went to Vical. Malone was listed as one inventor among several, but he no longer stood to profit personally from subsequent licensing deals, as he would have from any Salk-issued patents. Malone’s conclusion: “They got rich on the products of my mind.”</div><div>
</div><div><b>Verma and Felgner categorically deny Malone’s charges. “It’s complete nonsense,</b>” Verma told Nature. The decision to drop the patent application rested with the Salk’s technology-transfer office, he says. (Verma resigned from the Salk in 2018, following allegations of sexual harassment, which he continues to deny.)</div><div>
</div><div>Malone left Vical in August 1989, citing disagreements with Felgner over “scientific judgment” and “credit for my intellectual contributions”. He completed medical school and did a year of clinical training before working in academia, where he tried to continue research on mRNA vaccines but struggled to secure funding. (In 1996, for example, he unsuccessfully applied to a California state research agency for money to develop a mRNA vaccine to combat seasonal coronavirus infections.) Malone focused on DNA vaccines and delivery technologies instead.</div><div>
</div><div>In 2001, he moved into commercial work and consulting. And in the past few months, he has started publicly attacking the safety of the mRNA vaccines that his research helped to enable. Malone says, for instance, that proteins produced by vaccines can damage the body’s cells and that the risks of vaccination outweigh the benefits for children and young adults — claims that other scientists and health officials have repeatedly refuted.</div><div>
</div><div>Manufacturing challenges</div><div>In 1991, Vical entered into a multimillion-dollar research collaboration and licensing pact with US firm&nbsp;<b>Merck,&nbsp;</b>one of the world’s largest vaccine developers. Merck scientists evaluated the mRNA technology in mice with the aim of creating an influenza vaccine, but then abandoned that approach. “The cost and feasibility of manufacturing just gave us pause,” says Jeffrey Ulmer, a former Merck scientist who now consults with companies on vaccine-research issues.</div><div>
</div><div>Researchers at a small biotech firm in Strasbourg, France, called Transgène, felt the same way. There, in 1993, a team led by Pierre Meulien, working with industrial and academic partners, was the first to show that an mRNA in a liposome could elicit a specific antiviral immune response in mice8.&nbsp;<b>(Another exciting advance had come in 1992, when scientists at the Scripps Research Institute in La Jolla used mRNA to replace a deficient protein in rats, to treat a metabolic disorder9. But it would take almost two decades before independent labs reported similar success.</b>)......</div></div><div style="font-size: small; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman"></font></div></div><div><font face="Times New Roman" size="4">=</font></div><div><font face="Times New Roman" size="4"><a href="https://www.alternet.org/2021/05/vaccine/">https://www.alternet.org/2021/05/vaccine/</a></font></div><div><font face="Times New Roman" size="4">
</font></div><div><font face="Times New Roman" size="4">comm dr</font></div><div><font face="Times New Roman" size="4">
</font></div><div><p style=""><font size="4" face="Times New Roman" style="background-color: rgb(255, 255, 102);">While global health advocates applauded the Biden administration's recent&nbsp;<a href="https://www.commondreams.org/news/2021/05/05/transformative-hopeful-event-under-pressure-biden-backs-covid-19-vaccine-patent" rel="noopener noreferrer" target="blank" style="text-decoration-line: none; opacity: 1; transition: color 0.25s ease 0s, background 0.25s ease 0s, opacity 0.25s ease 0s;">decision</a>&nbsp;to support waiving intellectual property protections for Covid-19 vaccines as&nbsp;<a href="https://www.commondreams.org/newswire/2021/05/05/biden-administration-support-trips-waiver-critical-first-step-more-must-be-done" rel="noopener noreferrer" target="blank" style="text-decoration-line: none; opacity: 1; transition: color 0.25s ease 0s, background 0.25s ease 0s, opacity 0.25s ease 0s;">"critical,"</a>&nbsp;<a href="https://www.commondreams.org/newswire/2021/05/05/bidens-trips-waiver-decision-transformative-hopeful-event" rel="noopener noreferrer" target="blank" style="text-decoration-line: none; opacity: 1; transition: color 0.25s ease 0s, background 0.25s ease 0s, opacity 0.25s ease 0s;">"transformative,"</a>&nbsp;and&nbsp;<a href="https://www.commondreams.org/newswire/2021/05/05/bidens-support-trips-waiver-unquestionably-right-thing-do" rel="noopener noreferrer" target="blank" style="text-decoration-line: none; opacity: 1; transition: color 0.25s ease 0s, background 0.25s ease 0s, opacity 0.25s ease 0s;">"unquestionably the right thing to do,"</a>&nbsp;Big Pharma took a decidedly less optimistic view of the move and has been hard at work behind the scenes in a bid to thwart the policy, a&nbsp;<a href="https://theintercept.com/2021/05/14/covid-vaccine-waiver-generic-phrma-lobby/" rel="noopener noreferrer" target="blank" style="text-decoration-line: none; opacity: 1; transition: color 0.25s ease 0s, background 0.25s ease 0s, opacity 0.25s ease 0s;">report</a>&nbsp;published Friday by&nbsp;<em style="">The Intercept</em>&nbsp;revealed.</font></p><p style="background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman"><b>In a bid to stymie U.S. support for a proposal by India and South Africa to enact a Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver at the World Trade Organization (WTO), the pharmaceutical industry is "distributing talking points, organizing opposition, and even collecting congressional signatures in an attempt to reverse President Joe Biden's support for worldwide access to generic Covid-19 vaccines," according to&nbsp;<em>The Intercept's</em>&nbsp;Lee Fang.</b></font></p><p style=""><font size="4" face="Times New Roman" style="background-color: rgb(255, 204, 102);">Fang obtained an email from Jared Michaud, a lobbyist with the Pharmaceutical Research and Manufacturers of America (PhRMA)—a trade group whose clients include vaccine developers AstraZeneca, Johnson & Johnson, and Pfizer—describing how Big Pharma and sympathetic U.S. legislators are pushing lawmakers to oppose a TRIPS waiver.</font></p><p style="background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman"><b>The email explains that Reps. Buddy Carter (R-Ga.) and Vern Buchanan (R-Fla.) are leading an unreleased letter to Biden—which currently has 29 co-signers—"expressing concerns with the administration's support for waiving IP protections related to Covid-19 vaccines under the WTO TRIPS waiver."</b></font></p><p style="background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">"We urge you to contact offices and ask them to sign onto this letter," said Michaud's email.</font></p><p style="background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">The letter additionally claims that the TRIPS waiver would cost U.S. jobs and be a boon for China, which would "profit from our innovation."</font></p><p style="background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">Michaud's email contains&nbsp;<a href="https://www.documentcloud.org/documents/20708985-trips-waiver-national-security-threats" rel="noopener noreferrer" target="blank" style="text-decoration-line: none; opacity: 1; transition: color 0.25s ease 0s, background 0.25s ease 0s, opacity 0.25s ease 0s;">talking points</a>&nbsp;that paint the IP waiver as a national security threat that would "irreversibly damage American innovators" and the U.S. government's "strategic engagement," while a separate document marked "confidential" claims that "waiving intellectual property will undermine the global response to the pandemic and compromise vaccine safety."</font></p><p style="background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">According to Fang, "The metadata for the document shows that the PDF document was created by Megan Van Etten, an international public affairs specialist for PhRMA."</font></p><p style=""><font size="4" face="Times New Roman" style="background-color: rgb(255, 204, 102);">Fang notes that PhRMA&nbsp;<a href="https://www.opensecrets.org/federal-lobbying/clients/summary?cycle=2021&id=d000000504" rel="noopener noreferrer" target="blank" style="text-decoration-line: none; opacity: 1; transition: color 0.25s ease 0s, background 0.25s ease 0s, opacity 0.25s ease 0s;">spent</a>&nbsp;$24 million on lobbying at the federal level last year "and is one of the biggest corporate players in election spending."</font></p><p style="background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman"><b><a href="https://www.opensecrets.org/news/2021/05/big-pharma-shatters-q1-lobby/?utm_source=twitter&utm_medium=social&utm_campaign=twitt_bigphrml-05/04/20" rel="noopener noreferrer" target="blank" style="text-decoration-line: none; opacity: 1; transition: color 0.25s ease 0s, background 0.25s ease 0s, opacity 0.25s ease 0s;">According to</a>&nbsp;OpenSecrets, PhRMA has spent $8.7 million on lobbying so far this year. This, as client Pfizer has&nbsp;<a href="https://www.nytimes.com/2021/05/04/business/pfizer-covid-vaccine-profits.html?action=click&module=Top%20Stories&pgtype=Homepage" rel="noopener noreferrer" target="blank" style="text-decoration-line: none; opacity: 1; transition: color 0.25s ease 0s, background 0.25s ease 0s, opacity 0.25s ease 0s;">raked in $3.5 billion in profits</a>&nbsp;from the sale of its Covid-19 vaccine in just the first three months of 2021.</b></font></p><p style="background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">"The group has long shaped drug policy not only domestically but also in the international arena," writes Fang. "PhRMA&nbsp;<a href="https://medium.com/righttohealth-weekly/spotlight-on-south-africa-98389c219a8d" rel="noopener noreferrer" target="blank" style="text-decoration-line: none; opacity: 1; transition: color 0.25s ease 0s, background 0.25s ease 0s, opacity 0.25s ease 0s;">led the push&nbsp;</a>in the late 1990s to pressure South African President Nelson Mandela to drop efforts to break patent laws and allow for the importation and manufacture of generic HIV/AIDS medications, which at the time cost an annual $10,000-$15,000 per patient."</font></p><p style="background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">Progressive U.S. lawmakers have taken Big Pharma and its lobbyists to task for their opposition to Covid-19 vaccine patent waivers.</font></p><p style="background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">"Amid a global pandemic, major pharmaceutical companies are lobbying to protect billions in profits," Sen. Bernie Sanders (I-Vt.)&nbsp;<a href="https://www.commondreams.org/news/2021/03/04/outrageous-says-sanders-after-corporate-lobby-calls-sharing-vaccine-recipe-worlds" rel="noopener noreferrer" target="blank" style="text-decoration-line: none; opacity: 1; transition: color 0.25s ease 0s, background 0.25s ease 0s, opacity 0.25s ease 0s;">said</a>&nbsp;in March following the U.S. Chamber of Commerce's dismissal of the proposed TRIPS waiver as "misguided."
</font></p><div class="around-the-web" style="background-color: rgb(255, 255, 255);"><div class="from-your-siteheadline" style="font-weight: 700; text-transform: uppercase;"><font size="4" face="Times New Roman">FROM YOUR SITE ARTICLES</font></div><ul class="around-the-weblist" style="margin: 0px; padding: 0px; display: inline-block; width: 589.446px; list-style: none;"><font size="4" face="Times New Roman" /><li class="from-your-siteitem"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><a href="https://www.alternet.org/2021/04/vaccine-side-effects/" class="from-your-sitelink" target="blank" rel="noopener noreferrer" style="text-decoration-line: none; opacity: 1; transition: color 0.25s ease 0s, background 0.25s ease 0s, opacity 0.25s ease 0s; font-weight: lighter; line-height: normal; display: inline-block; margin-top: 10px;">Here's the truth about the COVID vaccine side effects - Alternet.org ›</a></font></font></font></font></font></font></font></font></font></font></li><li class="from-your-siteitem"><a href="https://www.alternet.org/2021/03/biden-vaccine-plan/" class="from-your-sitelink" target="blank" rel="noopener noreferrer" style="text-decoration-line: none; opacity: 1; transition: color 0.25s ease 0s, background 0.25s ease 0s, opacity 0.25s ease 0s; font-weight: lighter; line-height: normal; display: inline-block; margin-top: 10px;">Republicans are trying to sabotage Biden's COVID vaccine plan ... ›</a></li><li class="from-your-siteitem"><a href="https://www.alternet.org/2021/05/big-pharma/" class="from-your-sitelink" target="blank" rel="noopener noreferrer" style="text-decoration-line: none; opacity: 1; transition: color 0.25s ease 0s, background 0.25s ease 0s, opacity 0.25s ease 0s; font-weight: lighter; line-height: normal; display: inline-block; margin-top: 10px;">Exposed: Big pharma's plot to twart US Covid-19 vaccine waiver ... ›</a></li></ul></div></div><div><font face="Times New Roman" size="4">=
</font><div><font face="Times New Roman" size="4">beware FT</font></div><div><font face="Times New Roman" size="4">
</font></div><div><a href="https://www.ft.com/content/1a25aeb9-f645-434f-b3e1-4ab62cf5ebed"><font size="4" face="Times New Roman" color="#000000">https://www.ft.com/content/1a25aeb9-f645-434f-b3e1-4ab62cf5ebed</font></a></div><div><font size="4" face="Times New Roman">no lnx</font></div><div><font size="4" face="Times New Roman">
</font></div><div><h1 class="topperheadline" data-trackable="header" style="line-height: 40px; font-weight: 400; margin: 0px 0px 24px;"><span class="article-classifiergap"><font size="4" face="Times New Roman">US backs away from WHO move on access to Covid-19 treatments</font></span></h1><div class="topper__standfirst" style="line-height: 24px; margin-bottom: 0px; opacity: 0.8;"><font size="4" face="Times New Roman">Trump warns US will quit body if it fails to ‘commit to substantive improvements in next 30 days’</font></div></div><div><font size="4" face="Times New Roman">...</font><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman"><span style="white-space:pre"> </span>https://www.ft.com/content/1a25aeb9-f645-434f-b3e1-4ab62cf5ebed</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman"><b><span style="white-space:pre"> </span> US has rejected wording in a World Health Organization resolution that backs the rights of poor countries to ignore patents in order to gain access to a Covid-19 vaccine or treatment.</b></font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">Washington dissociated itself on Tuesday from elements of a motion passed by WHO members, saying that it sent “the wrong message to innovators who will be essential to the solutions the whole world needs”.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">Many governments, particularly in Africa, fear they will be squeezed out by richer countries unless they can force companies that discover anti-Covid-19 therapies to share their intellectual property with manufacturers able to produce them cheaply at scale.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">African ambassadors in Geneva, where the WHO is based, said US diplomats had sought to persuade them to support a dilution of language in the resolution, a proposal they had rejected.&nbsp;</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">Washington did not vote against the resolution proposed by the EU and others but instead issued a statement that repudiated the wording of several parts of it, including three paragraphs relating to emerging Covid-19 therapies. These included references to the so-called Doha Declaration, in which World Trade Organization ministers said governments could overrule intellectual property in a public health emergency.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">“The United States recognises the importance of access to affordable, safe, high-quality, and effective health products and the critical role that intellectual property plays in incentivising the development of new and improved health products,” the US said in an objection note. “However, as currently drafted, [the three paragraphs] send the wrong message to innovators who will be essential to the solutions the whole world needs.”</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman"><b>The move comes as US president Donald Trump has threatened to pull out of the WHO unless it demonstrates its independence from China in an escalation of his efforts to blame Beijing for the virus emergency.</b></font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman" style="background-color: rgb(255, 255, 102);">In a letter published late on Monday, Mr Trump warned that the US would permanently end funding to the international body if it failed to “commit to major substantive improvements in the next 30 days”.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">The US president castigated the WHO and Tedros Adhanom Ghebreyesus, its director-general, for “repeated mis-steps” in its coronavirus pandemic response that had proved “extremely costly for the world”.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">Mr Trump accused the WHO of neglecting to share information about the initial Covid-19 outbreak in China, failing to press Beijing sufficiently for answers, and of making “grossly inaccurate or misleading” claims about the disease. The WHO has previously denied the allegations.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">The resolution over patents is being discussed at a virtual two-day meeting of the World Health Assembly, the WHO’s governing body, which concludes on Tuesday.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">“The US made some input trying to water down the references to Trips and patenting,” said one west African ambassador to Geneva, referring to Trade-Related Aspects of Intellectual Property Rights. “The US is certain they will be the first to get the vaccine, but it might not be true.”</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">[Recommended</font></div><div><font size="4" face="Times New Roman">Jennifer Prah Ruger</font></div><div><font size="4" face="Times New Roman">The World Health Organization can be reformed]</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">Illustrating the concerns about richer countries getting earlier access to any vaccine, Ellen ‘t Hoen, director of the research group Medicines Law & Policy, said it took a decade for African countries to get affordable Aids medicines, during which time millions of people died.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">“What we have seen in the past is that high-income countries rush to the front of the queue and leave the rest of the world to fend for themselves,” she said.&nbsp;</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">The US and other nations with strong pharmaceutical sectors, including the UK, Switzerland and Japan, had wanted language explicitly referring to the Doha Declaration removed from the resolution, according to an early draft seen by the Financial Times.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">They wanted instead to emphasise the role of intellectual property in promoting innovation and to encourage equitable access to any Covid-19 vaccine or treatment through voluntary mechanisms, including donations and partnerships.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">The debate over intellectual property is part of a broader tussle between China and the US over who develops a vaccine first and how it will be distributed.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman"><b style="background-color: rgb(255, 204, 102);">Xi Jinping, China’s president, on Monday appeared to back the position of developing countries, when he said any vaccine “will be treated as a public good”.</b></font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">As the source of the outbreak, China has a special responsibility to pay more and to give more</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">John Ullyot, White House National Security Council]</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman"><b>In an address to the World Health Assembly — itself controversial because of US accusations that Beijing covered up the initial Covid-19 outbreak in the Chinese city of Wuhan — Mr Xi said China would donate $2bn over two years to respond to the crisis, especially in developing countries.</b></font></div><div><font size="4" face="Times New Roman" style="background-color: rgb(255, 255, 102);">
</font></div><div><font size="4" face="Times New Roman" style="background-color: rgb(255, 255, 102);">The White House described the Chinese offer as a “token to distract from calls from a growing number of nations demanding accountability for the Chinese government’s failure to meet its obligations?.?.?.?to tell the truth and warn the world of what was coming”.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">John Ullyot, the White House National Security Council spokesman, added that “as the source of the outbreak, China has a special responsibility to pay more and to give more” to the global health body.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">Diplomats said Washington had pushed strongly for language calling for an independent investigation “at the earliest possible opportunity” into the WHO-led response to the outbreak.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">In a letter seen by the Financial Times, African ambassadors in Geneva said attacks on the WHO’s Mr Tedros “from some quarters” had an “unfortunate racial overtone”. In the letter, first published in Africa Confidential, a specialist newsletter, the ambassadors said in an apparent dig at Washington that “failures at the national level should not be attributed to the WHO”.&nbsp;</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">In April, Mr Trump said the US would suspend funding of the WHO. Some diplomats thought an independent inquiry could be a precondition for Washington to resume contributions. Mr Trump on Monday did not comment on the Chinese announcements but repeated his recent attacks on the WHO, saying it was “a puppet of China”.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">=</font></div><div><font size="4" face="Times New Roman">https://YYY.theguardian.com/commentisfree/2020/may/20/coronavirus-patents-testing-us-senate</font></div><div><font size="4" face="Times New Roman">
</font></div><div><div><font size="4" face="Times New Roman">...Freed from overbroad patents on fundamental knowledge, we see an explosion of efforts to build and disseminate new tools to fight Covid-19, including 3-D printed and open source masks and ventilators and clinical trials on dozens of potential treatments and vaccines. While the US lags on deploying diagnostic testing, inventors are busily inventing: the FDA has authorized dozens of different Covid-19 tests. Some inventors may be motivated by the patent incentive – companies can still get patents, just within limits. But much is driven by altruism, love of science and the reputation that comes from inventing something that saves millions of lives. Today, no one company monopolizes Covid-19 testing, and all benefit.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman"><b>Yet some patent holders and their allies are unwisely threatening this balance. Last year, with support from the largest pharmaceutical and biotech industry trade groups, Senators Chris Coons and Thom Tillis proposed a bill that would undo Mayo, Myriad, and Alice, expanding limits on patent eligibility</b>. Pro-patent voices are now using the Covid-19 crisis to push the Coons-Tillis bill, asserting that broad patents on now-patent-ineligible subject matter are necessary to incentivize invention of anti-Covid technologies, especially diagnostic tests. That ignores evidence that the biggest problems we face are global shortages of unpatented basic supplies like nasal swabs and a failure of federal government coordination, not a shortage of inventive activity.</font></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">Congress should reject these efforts to undo the traditional balance and expand the scope of patent eligibility. The current legal standard may not be perfect, but it is working. In the Covid-19 crisis, Congress should focus instead on policies that give healthcare workers, other essential workers, patients, and all Americans the resources they need....</font></div><div><font size="4" face="Times New Roman">no lnx</font></div></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">=</font></div></div><div><font size="4" face="Times New Roman">=</font></div><div><a href="https://www.usatoday.com/story/news/factcheck/2020/05/15/fact-check-china-doesnt-own-patent-covid-19-treatment-remdesivir/5194192002/"><font size="4" face="Times New Roman" color="#000000">https://www.usatoday.com/story/news/factcheck/2020/05/15/fact-check-china-doesnt-own-patent-covid-19-treatment-remdesivir/5194192002/</font></a></div><div><font size="4" face="Times New Roman">
</font></div><div><font size="4" face="Times New Roman">the&nbsp;</font></div><h2 class="gnt_ar_b_h2" style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; line-height: 26px; margin: 28px 0px 18px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">&nbsp;claim: China owns the patent&nbsp;for the drug remdesivir</font></h2><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">The origins, utility and ownership of potential coronavirus treatments are an increasingly discussed subject online, making the topic a ripe target for conspiracy theories.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">The drug remdesivir has emerged as a centerpiece of many theories claiming that various groups and individuals stand to benefit from the drug's use as a treatment for COVID-19.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">“Isn’t it just an interesting coincidence that Remdesivir is made by Gilead and is the 'CURE'&nbsp;for COVID-19 … . And here’s where it gets interesting China holds the patent on the drug through an agreement with Gilead’s drug patent sharing subsidy branch called UNITAID who has an office near Wuhan,”&nbsp;<a href="https://www.facebook.com/photo.php?fbid=10212873886320710&set=a.1267424704496&type=3&theater" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">a graphic on Facebook shared more than 300 times reads</a>.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">And you’ll never guess who are the main financial investors in UNITAID…none other than George Soros, Bill & Melinda Gates, and WHO,” the post continues.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">Remdesivir is an antiviral drug developed by the firm Gilead Sciences, which maintains the&nbsp;U.S. patent on the drug as a coronavirus treatment. No Chinese institution has a recognized patent for the drug.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman"><strong class="gnt_ar_b_al" style="margin-right: 3px;">Fact check:&nbsp;</strong><a href="https://www.usatoday.com/story/news/factcheck/2020/03/23/coronavirus-fact-check-whats-true-and-whats-false-covid-19/2898043001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">What's true and what's false about coronavirus?</a></font></p><h2 class="gnt_ar_b_h2" style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; line-height: 26px; margin: 28px 0px 18px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">Remdesivir’s patents</font></h2><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman"><a href="https://www.gilead.com/purpose/advancing-global-health/covid-19/about-remdesivir" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Remdesivir&nbsp;</a>has been&nbsp;<a href="https://www.gilead.com/-/media/gilead-corporate/files/pdfs/covid-19/gilead_rdv-development-fact-sheet-2020.pdf" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">researched by Gilead as far back as 2009</a>&nbsp;as a treatment for viruses ranging from hepatitis C and respiratory syncytial virus to Ebola and now COVID-19.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">Gilead first&nbsp;<a href="https://patents.google.com/patent/US9724360B2/en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">received a patent for the drug</a>&nbsp;as a treatment for Ebola in 2017. In fall 2015, Gilead applied for two patents for remdesivir, one for&nbsp;<a href="https://patents.google.com/patent/US10251904B2/en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">combating coronaviruses</a>&nbsp;and&nbsp;<a href="https://patents.google.com/patent/US9724360B2/en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">another for filoviruses</a>, the family of pathogens that includes Ebola. Both were approved in spring 2019.&nbsp;</font></p><h2 class="gnt_ar_b_h2" style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; line-height: 26px; margin: 28px 0px 18px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">Use treating COVID-19</font></h2><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman"><a href="https://www.nih.gov/news-events/news-releases/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">In April, a National Institutes of Health study</a>&nbsp;found the drug to speed the recovery time of critically ill COVID-19 patients by 31%. Gilead has since said that, with federal assistance, it will begin&nbsp;<a href="https://www.usatoday.com/story/money/business/2020/05/03/coronavirus-treatment-drug-remdesivir-coming-hospitals-week/3074612001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">deploying remdesivir to hospitals around the country</a>.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px;"><font size="4" face="Times New Roman" style=""><b style="background-color: rgb(255, 204, 102);">Gilead Sciences remains the only organization in the world entitled to intellectual property rights over remdesivir&nbsp;as a treatment for COVID-19.</b></font></p><p class="gnt_ar_b_p" style="margin: 14px 0px;"><font size="4" face="Times New Roman" style="background-color: rgb(255, 255, 102);">In January, Chinese researchers at the Wuhan Institute of Virology&nbsp;<a href="https://www.bloomberg.com/news/articles/2020-02-05/china-is-trying-to-patent-gilead-s-experimental-coronavirus-drug" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">filed for a patent to use remdesivir</a>&nbsp;as a treatment against COVID-19. At the time, no research had been published showing that remdesivir was effective. Even so, the drug was already&nbsp;<a href="http://www.xinhuanet.com/english/2020-02/11/c_138771962.htm" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">being deployed for clinical trials in Wuhan</a>&nbsp;and elsewhere.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px;"><font size="4" face="Times New Roman" style="background-color: rgb(255, 255, 102);">In early February, the Chinese company BrightGene Bio-Medical Technology also said that it had been&nbsp;<a href="https://www.thepharmaletter.com/in-brief/brief-china-s-brightgene-latest-to-copy-remdesivir-antiviral" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">approved to&nbsp;produce remdesivir</a>&nbsp;by the Chinese government, though&nbsp;<a href="https://time.com/5793357/china-company-censured-coronavirus/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">regulators eventually said the company had not received approval&nbsp;</a>from the government nor Gilead Sciences.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px;"><font size="4" face="Times New Roman" style="background-color: rgb(255, 255, 102);">The Chinese government has not approved a patent for the drug, a move that would likely&nbsp;<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156563/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">draw further criticism from the United States</a>&nbsp;and others concerned about Chinese violations of international norms regarding intellectual property.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">Given the severity of the pandemic globally, however, several international groups have made repeated calls for the sharing of intellectual property rights relating to&nbsp;medicines and vaccines that can combat the new coronavirus.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman"><strong class="gnt_ar_b_al" style="margin-right: 3px;">Video:</strong><a href="https://www.usatoday.com/videos/news/health/2020/04/30/remdesivir-antiviral-drug-tested-against-covid-19/3061178001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">What to know about antiviral drug remdesivir and COVID-19</a></font></p><h2 class="gnt_ar_b_h2" style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; line-height: 26px; margin: 28px 0px 18px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">Unitaid, Gates Foundation, WHO and potential international cooperation on&nbsp;treatments</font></h2><p class="gnt_ar_b_p" style="margin: 14px 0px;"><font size="4" face="Times New Roman" style="background-color: rgb(255, 255, 102);"><a href="https://unitaid.org/about-us/#en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Unitaid&nbsp;</a>is not a subsidiary of Gilead Sciences but rather a global health research initiative backed by the&nbsp;<a href="https://www.un.org/en/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">United Nations</a>&nbsp;and&nbsp;<a href="https://www.who.int/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">World Health Organization</a>&nbsp;to fund research projects combating a range of viruses.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">Founded by the French government in 2006, the group is headquartered in Geneva and&nbsp;<a href="https://unitaid.org/how-we-work/donors/#en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">funded by the governments</a>&nbsp;of Brazil, Chile, France, Norway, South Korea, Spain and the United Kingdom, as well as the&nbsp;<a href="https://unitaid.org/news-blog/unitaid-hails-new-us-50-million-contribution-bill-melinda-gates-foundation/#en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Bill & Melinda Gates Foundation</a>.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px;"><font size="4" face="Times New Roman" style="background-color: rgb(255, 204, 102);">Unitaid has no financial ties to George Soros or the Open Society Foundations, which Soros founded and manages.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman"><b>The Bill & Melinda Gates Foundation&nbsp;<a href="https://www.usatoday.com/story/news/factcheck/2020/05/14/fact-check-anthony-fauci-bill-gates-wont-profit-remdesivir/3120063001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">also does not have a patent</a>&nbsp;for the remdesivir and doesn't stand to profit from its use.</b></font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman"><strong class="gnt_ar_b_al" style="margin-right: 3px;">Fact check:</strong><a href="https://www.usatoday.com/story/news/factcheck/2020/05/14/fact-check-anthony-fauci-bill-gates-wont-profit-remdesivir/3120063001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Dr. Anthony Fauci, Bill Gates won't profit from drug remdesivir</a></font></p><p class="gnt_ar_b_p" style="margin: 14px 0px;"><font size="4" face="Times New Roman" style="background-color: rgb(255, 255, 102);">In late March, Unitaid’s chair&nbsp;<a href="https://www.ft.com/content/b69afd98-a8af-40d9-b520-4231d9cac68f" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Marisol Touraine told the Financial Times</a>&nbsp;that “extraordinary circumstances” warranted “extraordinary solutions,” while endorsing a&nbsp;<a href="https://healthpolicy-watch.org/costa-rica-urges-who-to-lead-global-initiative-for-pooled-rights-to-covid-19-diagnostics-drugs-vaccines/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">WHO-backed plan for companies to voluntarily pool intellectual property</a>&nbsp;governing any treatments or research that can be used in the fight against COVID-19.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">“I welcome his initiative & call for pooled rights to #COVID19 diagnostics, drugs & vaccines,” Tedros Adhanom, director-general of the World Health Organization,&nbsp;<a href="https://twitter.com/DrTedros/status/1243090557804691468" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">said of the proposal</a>, which would allow companies around the world to share intellectual property rights and produce patented goods with the consent of other members in any such initiative.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">the strategy is an attempt to temper competition between firms and countries as the&nbsp;<a href="https://www.usatoday.com/story/news/health/2020/05/09/coronavirus-vaccine-race-us-testing/5179665002/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">race to find treatments and a potential vaccine for the new coronavirus intensifies</a>.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">On April 24, the WHO&nbsp;<a href="https://www.who.int/who-documents-detail/access-to-covid-19-tools-(act)-accelerator" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">launched a cooperative initiative</a>&nbsp;called “Access to COVID-19 Tools Accelerator,” which would coordinate and fund support for coronavirus research by member states and institutions. Unitaid and the Bill & Melinda Gates Foundation are listed as cosignatories.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">The United States and China are not members of the coalition,&nbsp;<a href="https://www.statnews.com/pharmalot/2020/04/24/covid19-coronavirus-who-vaccines-medicines-access/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">which may ultimately include a patent pooling resolution</a>. Gilead Sciences has not licensed the production of remdesivir to any other firm as it continues to ramp up production of the drug.</font></p><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman"><strong class="gnt_ar_b_al" style="margin-right: 3px;">Fact check:&nbsp;</strong><a href="https://www.usatoday.com/story/news/factcheck/2020/05/09/fact-check-price-didnt-push-remdesivir-over-hydroxychloroquine/3094440001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);">Price didn't drive promotion of remdesivir over hydroxychloroquine</a></font></p><h2 class="gnt_ar_b_h2" style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; line-height: 26px; margin: 28px 0px 18px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">Our ruling: False</font></h2><p class="gnt_ar_b_p" style="margin: 14px 0px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">No Chinese firm has an approved claim to a patent for remdesivir. No international organizations – including the Gates Foundations, Unitaid, the Open Societies Foundation, or the WHO – hold patents for the antiviral drug either. While there are efforts to pool patents for potential treatments, and thus&nbsp;alter the financial incentives of&nbsp;the parties to such pooling arrangements, the United States and China are not obligating their domestic firms to join these movements. Gilead Sciences, which owns the U.S. patent for promising COVID-19 treatment remdesivir, solely maintains&nbsp;the intellectual property rights to the drug. We rate this claim FALSE because it is not supported by our research.&nbsp;</font></p><h2 class="gnt_ar_b_h2" style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; line-height: 26px; margin: 28px 0px 18px; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">Our fact-check sources:</font></h2><ul class="gnt_ar_b_ul" style="list-style: none; padding: 0px 0px 0px 30px; background-color: rgb(255, 255, 255);"><li class="gnt_ar_b_ul_li"><a href="https://www.gilead.com/purpose/advancing-global-health/covid-19/about-remdesivir" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">Gilead Sciences, About Remdesivir</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://www.gilead.com/-/media/gilead-corporate/files/pdfs/covid-19/gilead_rdv-development-fact-sheet-2020.pdf" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">Gilead Sciences, Early Development of Remdesivir</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://patents.google.com/patent/US9724360B2/en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">Gilead Sciences 2017 Patent for Remdesivir</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://patents.google.com/patent/US10251904B2/en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">Gilead Sciences 2019 Patent for Remdesivir Usage Against Coronaviruses</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://patents.google.com/patent/US9724360B2/en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">Gilead Sciences 2019 Patent for Remdesivir Usage Against Filoviruses</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://www.nih.gov/news-events/news-releases/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">National Institutes of Health, NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://www.usatoday.com/story/money/business/2020/05/03/coronavirus-treatment-drug-remdesivir-coming-hospitals-week/3074612001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">USA TODAY, Coronavirus treatment drug remdesivir to arrive in hospitals this week, Gilead CEO says</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://www.bloomberg.com/news/articles/2020-02-05/china-is-trying-to-patent-gilead-s-experimental-coronavirus-drug" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">Bloomberg News, China Wants to Patent Gilead’s Experimental Coronavirus Drug</font></a></li><li class="gnt_ar_b_ul_li"><a href="http://www.xinhuanet.com/english/2020-02/11/c_138771962.htm" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">XinhuaNet, Over 60 percent of patients in clinical trial may try Remdesivir: expert</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://www.thepharmaletter.com/in-brief/brief-china-s-brightgene-latest-to-copy-remdesivir-antiviral" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">ThePharmaLetter, China's BrightGene latest to copy remdesivir antiviral</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://time.com/5793357/china-company-censured-coronavirus/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">Bloomberg, Chinese Biotech Company Censured for Claiming It Could Make Experimental Coronavirus Drug</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156563/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">European Journal of Risk Regulation, COVID-19, Patents and the Never-Ending Tension between Proprietary Rights and the Protection of Public Health</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://unitaid.org/about-us/#en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">Unitaid, About Us</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://unitaid.org/how-we-work/donors/#en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">Unitaid, Donors</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://unitaid.org/news-blog/unitaid-hails-new-us-50-million-contribution-bill-melinda-gates-foundation/#en" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">Gates Foundation, Press release about donation to Unitaid</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://www.usatoday.com/story/news/factcheck/2020/05/14/fact-check-anthony-fauci-bill-gates-wont-profit-remdesivir/3120063001/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">USA TODAY, Fact check: Dr. Anthony Fauci, Bill Gates won't profit from drug remdesivir</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://www.ft.com/content/b69afd98-a8af-40d9-b520-4231d9cac68f" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">Financial Times, Big drugmakers under pressure to share patents against coronavirus</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://twitter.com/DrTedros/status/1243090557804691468" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">Tedros Adhanom Ghebreyesus March 26 Tweet</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://www.usatoday.com/story/news/health/2020/05/09/coronavirus-vaccine-race-us-testing/5179665002/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">USA TODAY, Latest on global search for coronavirus vaccine: 1st US candidate set for Phase 2; WHO tracks 8 efforts; Pfizer tests in humans</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://www.who.int/who-documents-detail/access-to-covid-19-tools-(act)-accelerator" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">World Health Organization, Access to COVID-19 Tools Accelerator</font></a></li><li class="gnt_ar_b_ul_li"><a href="https://www.statnews.com/pharmalot/2020/04/24/covid19-coronavirus-who-vaccines-medicines-access/" target="blank" rel="noopener" data-t-l="|inline|intext|n/a" class="gnt_ar_b_a" style="text-decoration-color: rgb(0, 152, 254);"><font size="4" face="Times New Roman" color="#000000">STAT News, WHO launches ambitious global project to develop Covid-19 medical products</font></a></li></ul><div><font size="4" face="Times New Roman">=</font></div><div><font size="4" face="Times New Roman">
</font></div><div><h1 class="bNg8Rb" style="margin: 0px; padding: 0px; font-weight: normal; clip: rect(1px, 1px, 1px, 1px); height: 1px; overflow: hidden; position: absolute; white-space: nowrap; width: 1px; z-index: -1000; background-color: rgb(255, 255, 255);"><font size="4" face="Times New Roman">Search Results</font></h1><div eid="7vbGXvDlJoXcsAXiyargBg" data-async-context="query:covid%20patent%20remdesivir" id="rso" style="margin-top: 6px; background-color: rgb(255, 255, 255);"><div class="g" style="line-height: 1.2; width: 600px; margin-top: 0px; margin-bottom: 28px;"><h2 class="bNg8Rb" style="clip: rect(1px, 1px, 1px, 1px); height: 1px; margin: 0px; overflow: hidden; padding: 0px; position: absolute; white-space: nowrap; width: 1px; z-index: -1000;"><font size="4" face="Times New Roman">Web results</font></h2><div class="rc" data-hveid="CAQQAA" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFSgAMAB6BAgEEAA" style="position: relative;"><div class="r" style="margin: 0px; line-height: 1.58;"><a href="https://www.statnews.com/pharmalot/2020/05/08/gilead-remdesivir-covid19-coronavirus-patents/" ping="/url?sa=t&source=web&rct=j&url=https://www.statnews.com/pharmalot/2020/05/08/gilead-remdesivir-covid19-coronavirus-patents/&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFjAAegQIBBAB" style="cursor: pointer; text-decoration-line: none;"><font face="Times New Roman" color="#000000" size="4">
</font></a><h3 class="LC20lb DKV0Md" style="font-weight: normal; margin: 0px 0px 3px; padding: 4px 0px 0px; display: inline-block; line-height: 1.3;"><a href="https://www.statnews.com/pharmalot/2020/05/08/gilead-remdesivir-covid19-coronavirus-patents/" ping="/url?sa=t&source=web&rct=j&url=https://www.statnews.com/pharmalot/2020/05/08/gilead-remdesivir-covid19-coronavirus-patents/&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFjAAegQIBBAB" style="cursor: pointer; text-decoration-line: none;"><font face="Times New Roman" color="#000000" size="4">U.S. government contributed research to a Gilead remdesivir ...</font></a></h3><div class="TbwUpd NJjxre" style="display: inline-block; line-height: 1.58; padding-bottom: 1px; padding-top: 1px; text-size-adjust: none; position: absolute; left: 0px; top: 0px;"><cite class="iUh30 bc tjvcx" style="font-style: normal; padding-top: 1px; line-height: 1.3;"><font size="4" face="Times New Roman">www.statnews.com<span class="eipWBe" style="">&nbsp;› pharmalot › 2020/05/08 › gilead-...</span></font></cite></div><div class="B6fmyf" style="position: absolute; top: 0px; height: 0px; visibility: hidden; white-space: nowrap;"><font size="4" face="Times New Roman" /><div class="TbwUpd" style="display: inline-block; line-height: 1.58; padding-bottom: 1px; padding-top: 1px; text-size-adjust: none;"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><cite class="iUh30 bc tjvcx" style="font-style: normal; padding-top: 1px; line-height: 1.3;"><span class="eipWBe" style="" /></cite></font></font></font></font></font></font></font></font></font></font></font></font></font></div><div class="eFM0qc" style="display: inline-block; padding-bottom: 1px; padding-left: 2px; visibility: visible;"><div class="action-menu" style="display: inline; margin: 1px 3px 0px; position: relative; user-select: none; vertical-align: middle;"><a class="GHDvEf" href="https://www.google.com/search?ei=C_PGXqipEJDUsAWkkp6ICg&q=covid+patent+remdesivir&oq=covid+patent+remdesivir&gs_lcp=CgZwc3ktYWIQAzoCCAA6BAgAEEM6BAgAEAo6CAgAEBYQChAeUK0VWNE1YLQ8aABwAHgAgAHnA4gB8xeSAQkwLjUuMy4zLjGYAQCgAQGqAQdnd3Mtd2l6&sclient=psy-ab&ved=0ahUKEwjo2rrQ88XpAhUQKqwKHSSJB6EQ4dUDCAw&uact=5#" id="am-b0" aria-label="Result Options" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQ7B0wAHoECAQQBA" style="display: inline-block; height: 12px; margin-top: 1px; user-select: none; width: 13px; cursor: pointer; text-decoration-line: none;"><span class="mn-dwn-arw" style="border-color: rgb(112, 117, 122) transparent; border-style: solid; border-width: 5px 4px 0px; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -3px; position: absolute; left: 0px;" /></a><ol class="action-menu-panel" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQqR8wAHoECAQQBQ" style="margin: 0px; padding: 0px; border: 1px solid rgba(0, 0, 0, 0.2); position: absolute; left: 0px; top: 12px; visibility: hidden; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; z-index: 3; transition: opacity 0.218s ease 0s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px;"><li class="action-menu-item" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; cursor: pointer; user-select: none;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:9pbINI19jqsJ:https://www.statnews.com/pharmalot/2020/05/08/gilead-remdesivir-covid19-coronavirus-patents/+&cd=1&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:9pbINI19jqsJ:https://www.statnews.com/pharmalot/2020/05/08/gilead-remdesivir-covid19-coronavirus-patents/%2B%26cd%3D1%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAAegQIBBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div></div></div><div class="s" style="max-width: 48em; line-height: 1.58;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:9pbINI19jqsJ:https://www.statnews.com/pharmalot/2020/05/08/gilead-remdesivir-covid19-coronavirus-patents/+&cd=1&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:9pbINI19jqsJ:https://www.statnews.com/pharmalot/2020/05/08/gilead-remdesivir-covid19-coronavirus-patents/%2B%26cd%3D1%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAAegQIBBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;"><span class="st" style="line-height: 1.58; overflow-wrap: break-word;"><font size="4" face="Times New Roman" color="#000000"><span class="f" style="line-height: 1.58;">May 8, 2020 -&nbsp;</span>Two documents dating back to 2015 shed further light on the role the federal government played in discovering&nbsp;<span style="font-weight: bold;">remdesivir</span>&nbsp;and its use against&nbsp;...</font></span></a></div></div></div><div class="g" style="line-height: 1.2; width: 600px; margin-top: 0px; margin-bottom: 28px;"><div class="rc" data-hveid="CAMQAA" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFSgAMAF6BAgDEAA" style="position: relative;"><div class="r" style="margin: 0px; line-height: 1.58;"><a href="https://www.usatoday.com/story/news/factcheck/2020/05/15/fact-check-china-doesnt-own-patent-covid-19-treatment-remdesivir/5194192002/" ping="/url?sa=t&source=web&rct=j&url=https://www.usatoday.com/story/news/factcheck/2020/05/15/fact-check-china-doesnt-own-patent-covid-19-treatment-remdesivir/5194192002/&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFjABegQIAxAB" style="cursor: pointer; text-decoration-line: none;"><font face="Times New Roman" color="#000000" size="4">
</font></a><h3 class="LC20lb DKV0Md" style="font-weight: normal; margin: 0px 0px 3px; padding: 4px 0px 0px; display: inline-block; line-height: 1.3;"><a href="https://www.usatoday.com/story/news/factcheck/2020/05/15/fact-check-china-doesnt-own-patent-covid-19-treatment-remdesivir/5194192002/" ping="/url?sa=t&source=web&rct=j&url=https://www.usatoday.com/story/news/factcheck/2020/05/15/fact-check-china-doesnt-own-patent-covid-19-treatment-remdesivir/5194192002/&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFjABegQIAxAB" style="cursor: pointer; text-decoration-line: none;"><font face="Times New Roman" color="#000000" size="4">Fact check: China doesn't own patent for COVID-19 treatment ...</font></a></h3><div class="TbwUpd NJjxre" style="display: inline-block; line-height: 1.58; padding-bottom: 1px; padding-top: 1px; text-size-adjust: none; position: absolute; left: 0px; top: 0px;"><cite class="iUh30 bc tjvcx" style="font-style: normal; padding-top: 1px; line-height: 1.3;"><font size="4" face="Times New Roman">www.usatoday.com<span class="eipWBe" style="">&nbsp;› news › factcheck › 2020/05/15</span></font></cite></div><div class="B6fmyf" style="position: absolute; top: 0px; height: 0px; visibility: hidden; white-space: nowrap;"><font size="4" face="Times New Roman" /><div class="TbwUpd" style="display: inline-block; line-height: 1.58; padding-bottom: 1px; padding-top: 1px; text-size-adjust: none;"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><cite class="iUh30 bc tjvcx" style="font-style: normal; padding-top: 1px; line-height: 1.3;"><span class="eipWBe" style="" /></cite></font></font></font></font></font></font></font></font></font></font></font></font></font></div><div class="eFM0qc" style="display: inline-block; padding-bottom: 1px; padding-left: 2px; visibility: visible;"><div class="action-menu" style="display: inline; margin: 1px 3px 0px; position: relative; user-select: none; vertical-align: middle;"><a class="GHDvEf" href="https://www.google.com/search?ei=C_PGXqipEJDUsAWkkp6ICg&q=covid+patent+remdesivir&oq=covid+patent+remdesivir&gs_lcp=CgZwc3ktYWIQAzoCCAA6BAgAEEM6BAgAEAo6CAgAEBYQChAeUK0VWNE1YLQ8aABwAHgAgAHnA4gB8xeSAQkwLjUuMy4zLjGYAQCgAQGqAQdnd3Mtd2l6&sclient=psy-ab&ved=0ahUKEwjo2rrQ88XpAhUQKqwKHSSJB6EQ4dUDCAw&uact=5#" id="am-b1" aria-label="Result Options" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQ7B0wAXoECAMQBA" style="display: inline-block; height: 12px; margin-top: 1px; user-select: none; width: 13px; cursor: pointer; text-decoration-line: none;"><span class="mn-dwn-arw" style="border-color: rgb(112, 117, 122) transparent; border-style: solid; border-width: 5px 4px 0px; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -3px; position: absolute; left: 0px;" /></a><ol class="action-menu-panel" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQqR8wAXoECAMQBQ" style="margin: 0px; padding: 0px; border: 1px solid rgba(0, 0, 0, 0.2); position: absolute; left: 0px; top: 12px; visibility: hidden; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; z-index: 3; transition: opacity 0.218s ease 0s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px;"><li class="action-menu-item" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; cursor: pointer; user-select: none;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:wN-3SFMlN9IJ:https://www.usatoday.com/story/news/factcheck/2020/05/15/fact-check-china-doesnt-own-patent-covid-19-treatment-remdesivir/5194192002/+&cd=2&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:wN-3SFMlN9IJ:https://www.usatoday.com/story/news/factcheck/2020/05/15/fact-check-china-doesnt-own-patent-covid-19-treatment-remdesivir/5194192002/%2B%26cd%3D2%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDABegQIAxAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div></div></div><div class="s" style="max-width: 48em; line-height: 1.58;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:wN-3SFMlN9IJ:https://www.usatoday.com/story/news/factcheck/2020/05/15/fact-check-china-doesnt-own-patent-covid-19-treatment-remdesivir/5194192002/+&cd=2&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:wN-3SFMlN9IJ:https://www.usatoday.com/story/news/factcheck/2020/05/15/fact-check-china-doesnt-own-patent-covid-19-treatment-remdesivir/5194192002/%2B%26cd%3D2%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDABegQIAxAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;"><span class="st" style="line-height: 1.58; overflow-wrap: break-word;"><font size="4" face="Times New Roman" color="#000000"><span class="f" style="line-height: 1.58;">7 days ago -&nbsp;</span>A viral claim that China owns&nbsp;<span style="font-weight: bold;">remdesivir's patent</span>&nbsp;through an agreement with a multi-national public health organization called Unitaid is false.</font></span></a></div></div></div><div class="g" style="line-height: 1.2; width: 600px; margin-top: 0px; margin-bottom: 28px;"><div class="rc" data-hveid="CAYQAA" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFSgAMAJ6BAgGEAA" style="position: relative;"><div class="r" style="margin: 0px; line-height: 1.58;"><a href="https://www.wusa9.com/article/news/verify/verify-what-is-remdesivir-and-who-has-the-patent/507-ae00b396-a731-487c-8951-c15ec8668505" ping="/url?sa=t&source=web&rct=j&url=https://www.wusa9.com/article/news/verify/verify-what-is-remdesivir-and-who-has-the-patent/507-ae00b396-a731-487c-8951-c15ec8668505&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFjACegQIBhAB" style="cursor: pointer; text-decoration-line: none;"><font face="Times New Roman" color="#000000" size="4">
</font></a><h3 class="LC20lb DKV0Md" style="font-weight: normal; margin: 0px 0px 3px; padding: 4px 0px 0px; display: inline-block; line-height: 1.3;"><a href="https://www.wusa9.com/article/news/verify/verify-what-is-remdesivir-and-who-has-the-patent/507-ae00b396-a731-487c-8951-c15ec8668505" ping="/url?sa=t&source=web&rct=j&url=https://www.wusa9.com/article/news/verify/verify-what-is-remdesivir-and-who-has-the-patent/507-ae00b396-a731-487c-8951-c15ec8668505&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFjACegQIBhAB" style="cursor: pointer; text-decoration-line: none;"><font face="Times New Roman" color="#000000" size="4">VERIFY: What is remdesivir, and who has the patent? | wusa9 ...</font></a></h3><div class="TbwUpd NJjxre" style="display: inline-block; line-height: 1.58; padding-bottom: 1px; padding-top: 1px; text-size-adjust: none; position: absolute; left: 0px; top: 0px;"><cite class="iUh30 bc tjvcx" style="font-style: normal; padding-top: 1px; line-height: 1.3;"><font size="4" face="Times New Roman">www.wusa9.com<span class="eipWBe" style="">&nbsp;› article › news › verify-what-is-remd...</span></font></cite></div><div class="B6fmyf" style="position: absolute; top: 0px; height: 0px; visibility: hidden; white-space: nowrap;"><font size="4" face="Times New Roman" /><div class="TbwUpd" style="display: inline-block; line-height: 1.58; padding-bottom: 1px; padding-top: 1px; text-size-adjust: none;"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><cite class="iUh30 bc tjvcx" style="font-style: normal; padding-top: 1px; line-height: 1.3;"><span class="eipWBe" style="" /></cite></font></font></font></font></font></font></font></font></font></font></font></font></font></div><div class="eFM0qc" style="display: inline-block; padding-bottom: 1px; padding-left: 2px; visibility: visible;"><div class="action-menu" style="display: inline; margin: 1px 3px 0px; position: relative; user-select: none; vertical-align: middle;"><a class="GHDvEf" href="https://www.google.com/search?ei=C_PGXqipEJDUsAWkkp6ICg&q=covid+patent+remdesivir&oq=covid+patent+remdesivir&gs_lcp=CgZwc3ktYWIQAzoCCAA6BAgAEEM6BAgAEAo6CAgAEBYQChAeUK0VWNE1YLQ8aABwAHgAgAHnA4gB8xeSAQkwLjUuMy4zLjGYAQCgAQGqAQdnd3Mtd2l6&sclient=psy-ab&ved=0ahUKEwjo2rrQ88XpAhUQKqwKHSSJB6EQ4dUDCAw&uact=5#" id="am-b2" aria-label="Result Options" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQ7B0wAnoECAYQBA" style="display: inline-block; height: 12px; margin-top: 1px; user-select: none; width: 13px; cursor: pointer; text-decoration-line: none;"><span class="mn-dwn-arw" style="border-color: rgb(112, 117, 122) transparent; border-style: solid; border-width: 5px 4px 0px; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -3px; position: absolute; left: 0px;" /></a><ol class="action-menu-panel" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQqR8wAnoECAYQBQ" style="margin: 0px; padding: 0px; border: 1px solid rgba(0, 0, 0, 0.2); position: absolute; left: 0px; top: 12px; visibility: hidden; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; z-index: 3; transition: opacity 0.218s ease 0s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px;"><li class="action-menu-item" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; cursor: pointer; user-select: none;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:mKK2yIuHB4gJ:https://www.wusa9.com/article/news/verify/verify-what-is-remdesivir-and-who-has-the-patent/507-ae00b396-a731-487c-8951-c15ec8668505+&cd=3&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:mKK2yIuHB4gJ:https://www.wusa9.com/article/news/verify/verify-what-is-remdesivir-and-who-has-the-patent/507-ae00b396-a731-487c-8951-c15ec8668505%2B%26cd%3D3%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDACegQIBhAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div></div></div><div class="s" style="max-width: 48em; line-height: 1.58;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:mKK2yIuHB4gJ:https://www.wusa9.com/article/news/verify/verify-what-is-remdesivir-and-who-has-the-patent/507-ae00b396-a731-487c-8951-c15ec8668505+&cd=3&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:mKK2yIuHB4gJ:https://www.wusa9.com/article/news/verify/verify-what-is-remdesivir-and-who-has-the-patent/507-ae00b396-a731-487c-8951-c15ec8668505%2B%26cd%3D3%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDACegQIBhAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;"><span class="st" style="line-height: 1.58; overflow-wrap: break-word;"><font size="4" face="Times New Roman" color="#000000"><span class="f" style="line-height: 1.58;">May 6, 2020 -&nbsp;</span><span style="font-weight: bold;">Remdesivir</span>&nbsp;has recently been approved by the FDA to treat&nbsp;<span style="font-weight: bold;">COVID</span>-19. The VERIFY team has found that as a result, many questions and claims&nbsp;...</font></span></a></div></div></div><div class="g" style="line-height: 1.2; width: 600px; margin-top: 0px; margin-bottom: 28px;"><div class="rc" data-hveid="CAIQAA" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFSgAMAN6BAgCEAA" style="position: relative;"><div class="r" style="margin: 0px; line-height: 1.58;"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156563/" ping="/url?sa=t&source=web&rct=j&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156563/&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFjADegQIAhAB" style="cursor: pointer; text-decoration-line: none;"><font face="Times New Roman" color="#000000" size="4">
</font></a><h3 class="LC20lb DKV0Md" style="font-weight: normal; margin: 0px 0px 3px; padding: 4px 0px 0px; display: inline-block; line-height: 1.3;"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156563/" ping="/url?sa=t&source=web&rct=j&url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156563/&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFjADegQIAhAB" style="cursor: pointer; text-decoration-line: none;"><font face="Times New Roman" color="#000000" size="4">COVID-19, Patents and the Never-Ending Tension between ...</font></a></h3><div class="TbwUpd NJjxre" style="display: inline-block; line-height: 1.58; padding-bottom: 1px; padding-top: 1px; text-size-adjust: none; position: absolute; left: 0px; top: 0px;"><cite class="iUh30 bc tjvcx" style="font-style: normal; padding-top: 1px; line-height: 1.3;"><font size="4" face="Times New Roman">www.ncbi.nlm.nih.gov<span class="eipWBe" style="">&nbsp;› pmc › articles › PMC7156563</span></font></cite></div><div class="B6fmyf" style="position: absolute; top: 0px; height: 0px; visibility: hidden; white-space: nowrap;"><font size="4" face="Times New Roman" /><div class="TbwUpd" style="display: inline-block; line-height: 1.58; padding-bottom: 1px; padding-top: 1px; text-size-adjust: none;"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><cite class="iUh30 bc tjvcx" style="font-style: normal; padding-top: 1px; line-height: 1.3;"><span class="eipWBe" style="" /></cite></font></font></font></font></font></font></font></font></font></font></font></font></font></div><div class="eFM0qc" style="display: inline-block; padding-bottom: 1px; padding-left: 2px; visibility: visible;"><div class="action-menu" style="display: inline; margin: 1px 3px 0px; position: relative; user-select: none; vertical-align: middle;"><a class="GHDvEf" href="https://www.google.com/search?ei=C_PGXqipEJDUsAWkkp6ICg&q=covid+patent+remdesivir&oq=covid+patent+remdesivir&gs_lcp=CgZwc3ktYWIQAzoCCAA6BAgAEEM6BAgAEAo6CAgAEBYQChAeUK0VWNE1YLQ8aABwAHgAgAHnA4gB8xeSAQkwLjUuMy4zLjGYAQCgAQGqAQdnd3Mtd2l6&sclient=psy-ab&ved=0ahUKEwjo2rrQ88XpAhUQKqwKHSSJB6EQ4dUDCAw&uact=5#" id="am-b3" aria-label="Result Options" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQ7B0wA3oECAIQBA" style="display: inline-block; height: 12px; margin-top: 1px; user-select: none; width: 13px; cursor: pointer; text-decoration-line: none;"><span class="mn-dwn-arw" style="border-color: rgb(112, 117, 122) transparent; border-style: solid; border-width: 5px 4px 0px; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -3px; position: absolute; left: 0px;" /></a><ol class="action-menu-panel" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQqR8wA3oECAIQBQ" style="margin: 0px; padding: 0px; border: 1px solid rgba(0, 0, 0, 0.2); position: absolute; left: 0px; top: 12px; visibility: hidden; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; z-index: 3; transition: opacity 0.218s ease 0s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px;"><li class="action-menu-item" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; cursor: pointer; user-select: none;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:dTEgvx6ysSIJ:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156563/+&cd=4&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:dTEgvx6ysSIJ:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156563/%2B%26cd%3D4%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDADegQIAhAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div></div></div><div class="s" style="max-width: 48em; line-height: 1.58;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:dTEgvx6ysSIJ:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156563/+&cd=4&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:dTEgvx6ysSIJ:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156563/%2B%26cd%3D4%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDADegQIAhAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;"><span class="st" style="line-height: 1.58; overflow-wrap: break-word;"><font size="4" face="Times New Roman" color="#000000"><span class="f" style="line-height: 1.58;">Apr 11, 2020 -&nbsp;</span>In January 2020, Chinese researchers at the Wuhan Institute of Virology filed for a&nbsp;<span style="font-weight: bold;">patent</span>&nbsp;covering the use of&nbsp;<span style="font-weight: bold;">remdesivir</span>, an experimental&nbsp;...</font></span></a><div class="dhIWPd f" style="line-height: 1.58;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:dTEgvx6ysSIJ:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156563/+&cd=4&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:dTEgvx6ysSIJ:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156563/%2B%26cd%3D4%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDADegQIAhAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;"><font size="4" face="Times New Roman" color="#000000">by E BONADIO</font></a></div></div></div></div><div class="g" style="line-height: 1.2; width: 600px; margin-top: 0px; margin-bottom: 28px;"><div class="rc" data-hveid="CAEQAA" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFSgAMAR6BAgBEAA" style="position: relative;"><div class="r" style="margin: 0px; line-height: 1.58;"><a href="https://www.inquartik.com/inq-china-coronavirus-patents-gilead-portfolio/" ping="/url?sa=t&source=web&rct=j&url=https://www.inquartik.com/inq-china-coronavirus-patents-gilead-portfolio/&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFjAEegQIARAB" style="cursor: pointer; text-decoration-line: none;"><font face="Times New Roman" color="#000000" size="4">
</font></a><h3 class="LC20lb DKV0Md" style="font-weight: normal; margin: 0px 0px 3px; padding: 4px 0px 0px; display: inline-block; line-height: 1.3;"><a href="https://www.inquartik.com/inq-china-coronavirus-patents-gilead-portfolio/" ping="/url?sa=t&source=web&rct=j&url=https://www.inquartik.com/inq-china-coronavirus-patents-gilead-portfolio/&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFjAEegQIARAB" style="cursor: pointer; text-decoration-line: none;"><font face="Times New Roman" color="#000000" size="4">Coronavirus Patents: China Files for Remdesivir ... - InQuartik</font></a></h3><div class="TbwUpd NJjxre" style="display: inline-block; line-height: 1.58; padding-bottom: 1px; padding-top: 1px; text-size-adjust: none; position: absolute; left: 0px; top: 0px;"><cite class="iUh30 bc tjvcx" style="font-style: normal; padding-top: 1px; line-height: 1.3;"><font size="4" face="Times New Roman">www.inquartik.com<span class="eipWBe" style="">&nbsp;› inq-china-coronavirus-patents-gil...</span></font></cite></div><div class="B6fmyf" style="position: absolute; top: 0px; height: 0px; visibility: hidden; white-space: nowrap;"><font size="4" face="Times New Roman" /><div class="TbwUpd" style="display: inline-block; line-height: 1.58; padding-bottom: 1px; padding-top: 1px; text-size-adjust: none;"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><cite class="iUh30 bc tjvcx" style="font-style: normal; padding-top: 1px; line-height: 1.3;"><span class="eipWBe" style="" /></cite></font></font></font></font></font></font></font></font></font></font></font></font></font></div><div class="eFM0qc" style="display: inline-block; padding-bottom: 1px; padding-left: 2px; visibility: visible;"><div class="action-menu" style="display: inline; margin: 1px 3px 0px; position: relative; user-select: none; vertical-align: middle;"><a class="GHDvEf" href="https://www.google.com/search?ei=C_PGXqipEJDUsAWkkp6ICg&q=covid+patent+remdesivir&oq=covid+patent+remdesivir&gs_lcp=CgZwc3ktYWIQAzoCCAA6BAgAEEM6BAgAEAo6CAgAEBYQChAeUK0VWNE1YLQ8aABwAHgAgAHnA4gB8xeSAQkwLjUuMy4zLjGYAQCgAQGqAQdnd3Mtd2l6&sclient=psy-ab&ved=0ahUKEwjo2rrQ88XpAhUQKqwKHSSJB6EQ4dUDCAw&uact=5#" id="am-b4" aria-label="Result Options" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQ7B0wBHoECAEQBA" style="display: inline-block; height: 12px; margin-top: 1px; user-select: none; width: 13px; cursor: pointer; text-decoration-line: none;"><span class="mn-dwn-arw" style="border-color: rgb(112, 117, 122) transparent; border-style: solid; border-width: 5px 4px 0px; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -3px; position: absolute; left: 0px;" /></a><ol class="action-menu-panel" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQqR8wBHoECAEQBQ" style="margin: 0px; padding: 0px; border: 1px solid rgba(0, 0, 0, 0.2); position: absolute; left: 0px; top: 12px; visibility: hidden; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; z-index: 3; transition: opacity 0.218s ease 0s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px;"><li class="action-menu-item" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; cursor: pointer; user-select: none;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:ng57xuT8vGUJ:https://www.inquartik.com/inq-china-coronavirus-patents-gilead-portfolio/+&cd=5&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:ng57xuT8vGUJ:https://www.inquartik.com/inq-china-coronavirus-patents-gilead-portfolio/%2B%26cd%3D5%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAEegQIARAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div></div></div><div class="s" style="max-width: 48em; line-height: 1.58;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:ng57xuT8vGUJ:https://www.inquartik.com/inq-china-coronavirus-patents-gilead-portfolio/+&cd=5&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:ng57xuT8vGUJ:https://www.inquartik.com/inq-china-coronavirus-patents-gilead-portfolio/%2B%26cd%3D5%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAEegQIARAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;"><span class="st" style="line-height: 1.58; overflow-wrap: break-word;"><font size="4" face="Times New Roman" color="#000000"><span class="f" style="line-height: 1.58;">May 14, 2020 -&nbsp;</span>Analyze the&nbsp;<span style="font-weight: bold;">patent</span>&nbsp;portfolio of Gilead Sciences to understand the position of and how it may respond to the action of China applying for&nbsp;...</font></span></a></div></div></div><div class="g" style="line-height: 1.2; width: 600px; margin-top: 0px; margin-bottom: 28px;"><div class="rc" data-hveid="CAgQAA" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFSgAMAV6BAgIEAA" style="position: relative;"><div class="r" style="margin: 0px; line-height: 1.58;"><a href="https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ" ping="/url?sa=t&source=web&rct=j&url=https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFjAFegQICBAB" style="cursor: pointer; text-decoration-line: none;"><font face="Times New Roman" color="#000000" size="4">
</font></a><h3 class="LC20lb DKV0Md" style="font-weight: normal; margin: 0px 0px 3px; padding: 4px 0px 0px; display: inline-block; line-height: 1.3;"><a href="https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ" ping="/url?sa=t&source=web&rct=j&url=https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFjAFegQICBAB" style="cursor: pointer; text-decoration-line: none;"><font face="Times New Roman" color="#000000" size="4">Health groups ask India to rescind Gilead's patents for COVID ...</font></a></h3><div class="TbwUpd NJjxre" style="display: inline-block; line-height: 1.58; padding-bottom: 1px; padding-top: 1px; text-size-adjust: none; position: absolute; left: 0px; top: 0px;"><cite class="iUh30 bc tjvcx" style="font-style: normal; padding-top: 1px; line-height: 1.3;"><font size="4" face="Times New Roman">www.reuters.com<span class="eipWBe" style="">&nbsp;› article › health-groups-ask-india-to-...</span></font></cite></div><div class="B6fmyf" style="position: absolute; top: 0px; height: 0px; visibility: hidden; white-space: nowrap;"><font size="4" face="Times New Roman" /><div class="TbwUpd" style="display: inline-block; line-height: 1.58; padding-bottom: 1px; padding-top: 1px; text-size-adjust: none;"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><cite class="iUh30 bc tjvcx" style="font-style: normal; padding-top: 1px; line-height: 1.3;"><span class="eipWBe" style="" /></cite></font></font></font></font></font></font></font></font></font></font></font></font></font></div><div class="eFM0qc" style="display: inline-block; padding-bottom: 1px; padding-left: 2px; visibility: visible;"><div class="action-menu" style="display: inline; margin: 1px 3px 0px; position: relative; user-select: none; vertical-align: middle;"><a class="GHDvEf" href="https://www.google.com/search?ei=C_PGXqipEJDUsAWkkp6ICg&q=covid+patent+remdesivir&oq=covid+patent+remdesivir&gs_lcp=CgZwc3ktYWIQAzoCCAA6BAgAEEM6BAgAEAo6CAgAEBYQChAeUK0VWNE1YLQ8aABwAHgAgAHnA4gB8xeSAQkwLjUuMy4zLjGYAQCgAQGqAQdnd3Mtd2l6&sclient=psy-ab&ved=0ahUKEwjo2rrQ88XpAhUQKqwKHSSJB6EQ4dUDCAw&uact=5#" id="am-b5" aria-label="Result Options" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQ7B0wBXoECAgQBA" style="display: inline-block; height: 12px; margin-top: 1px; user-select: none; width: 13px; cursor: pointer; text-decoration-line: none;"><span class="mn-dwn-arw" style="border-color: rgb(112, 117, 122) transparent; border-style: solid; border-width: 5px 4px 0px; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -3px; position: absolute; left: 0px;" /></a><ol class="action-menu-panel" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQqR8wBXoECAgQBQ" style="margin: 0px; padding: 0px; border: 1px solid rgba(0, 0, 0, 0.2); position: absolute; left: 0px; top: 12px; visibility: hidden; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; z-index: 3; transition: opacity 0.218s ease 0s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px;"><li class="action-menu-item" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; cursor: pointer; user-select: none;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div></div></div><div class="s" style="max-width: 48em; line-height: 1.58;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;"><span class="st" style="line-height: 1.58; overflow-wrap: break-word;"><font size="4" face="Times New Roman" color="#000000"><span class="f" style="line-height: 1.58;">May 14, 2020 -&nbsp;</span>Two health advocacy groups have written to the Indian government asking it to rescind&nbsp;<span style="font-weight: bold;">patents</span>&nbsp;given to Gilead Sciences for the drug&nbsp;<span style="font-weight: bold;">remdesivir</span>&nbsp;...</font></span></a></div></div></div><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;"><font size="4" face="Times New Roman" color="#000000"><span id="fld" /></font></a><div class="g" style="line-height: 1.2; width: 600px; margin-top: 0px; margin-bottom: 28px;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><div class="rc" data-hveid="CAUQAA" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFSgAMAZ6BAgFEAA" style="position: relative;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><div class="r" style="margin: 0px; line-height: 1.58;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ+&cd=6&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:1JI-wiEZ-bwJ:https://www.reuters.com/article/us-health-coronavirus-india-remdesivir/health-groups-ask-india-to-rescind-gileads-patents-for-covid-19-drug-remdesivir-idUSKBN22Q1EJ%2B%26cd%3D6%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAFegQICBAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /><a href="https://www.bizjournals.com/sanfrancisco/news/2020/05/04/gileads-drug-pricing-in-the-crosshairs-again-in.html" ping="/url?sa=t&source=web&rct=j&url=https://www.bizjournals.com/sanfrancisco/news/2020/05/04/gileads-drug-pricing-in-the-crosshairs-again-in.html&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFjAGegQIBRAB" style="cursor: pointer; text-decoration-line: none;"><font face="Times New Roman" color="#000000" size="4">
</font></a><h3 class="LC20lb DKV0Md" style="font-weight: normal; margin: 0px 0px 3px; padding: 4px 0px 0px; display: inline-block; line-height: 1.3;"><a href="https://www.bizjournals.com/sanfrancisco/news/2020/05/04/gileads-drug-pricing-in-the-crosshairs-again-in.html" ping="/url?sa=t&source=web&rct=j&url=https://www.bizjournals.com/sanfrancisco/news/2020/05/04/gileads-drug-pricing-in-the-crosshairs-again-in.html&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQFjAGegQIBRAB" style="cursor: pointer; text-decoration-line: none;"><font face="Times New Roman" color="#000000" size="4">Gilead's drug pricing in the crosshairs again in wake of OK to ...</font></a></h3><div class="TbwUpd NJjxre" style="display: inline-block; line-height: 1.58; padding-bottom: 1px; padding-top: 1px; text-size-adjust: none; position: absolute; left: 0px; top: 0px;"><cite class="iUh30 bc tjvcx" style="font-style: normal; padding-top: 1px; line-height: 1.3;"><font size="4" face="Times New Roman">www.bizjournals.com<span class="eipWBe" style="">&nbsp;› news › 2020/05/04 › gileads-dr...</span></font></cite></div><div class="B6fmyf" style="position: absolute; top: 0px; height: 0px; visibility: hidden; white-space: nowrap;"><font size="4" face="Times New Roman" /><div class="TbwUpd" style="display: inline-block; line-height: 1.58; padding-bottom: 1px; padding-top: 1px; text-size-adjust: none;"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><font size="4" face="Times New Roman"><cite class="iUh30 bc tjvcx" style="font-style: normal; padding-top: 1px; line-height: 1.3;"><span class="eipWBe" style="" /></cite></font></font></font></font></font></font></font></font></font></font></font></font></font></div><div class="eFM0qc" style="display: inline-block; padding-bottom: 1px; padding-left: 2px; visibility: visible;"><div class="action-menu" style="display: inline; margin: 1px 3px 0px; position: relative; user-select: none; vertical-align: middle;"><a class="GHDvEf" href="https://www.google.com/search?ei=C_PGXqipEJDUsAWkkp6ICg&q=covid+patent+remdesivir&oq=covid+patent+remdesivir&gs_lcp=CgZwc3ktYWIQAzoCCAA6BAgAEEM6BAgAEAo6CAgAEBYQChAeUK0VWNE1YLQ8aABwAHgAgAHnA4gB8xeSAQkwLjUuMy4zLjGYAQCgAQGqAQdnd3Mtd2l6&sclient=psy-ab&ved=0ahUKEwjo2rrQ88XpAhUQKqwKHSSJB6EQ4dUDCAw&uact=5#" id="am-b6" aria-label="Result Options" aria-expanded="false" aria-haspopup="true" role="button" jsaction="m.tdd;keydown:m.hbke;keypress:m.mskpe" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQ7B0wBnoECAUQBA" style="display: inline-block; height: 12px; margin-top: 1px; user-select: none; width: 13px; cursor: pointer; text-decoration-line: none;"><span class="mn-dwn-arw" style="border-color: rgb(112, 117, 122) transparent; border-style: solid; border-width: 5px 4px 0px; width: 0px; height: 0px; margin-left: 3px; top: 7.5px; margin-top: -3px; position: absolute; left: 0px;" /></a><ol class="action-menu-panel" role="menu" tabindex="-1" jsaction="keydown:m.hdke;mouseover:m.hdhne;mouseout:m.hdhue" data-ved="2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQqR8wBnoECAUQBQ" style="margin: 0px; padding: 0px; border: 1px solid rgba(0, 0, 0, 0.2); position: absolute; left: 0px; top: 12px; visibility: hidden; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; z-index: 3; transition: opacity 0.218s ease 0s; box-shadow: rgba(0, 0, 0, 0.2) 0px 2px 4px;"><li class="action-menu-item" role="menuitem" style="margin: 0px; padding: 0px; border: 0px; list-style: none; cursor: pointer; user-select: none;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:QxN148pTFoMJ:https://www.bizjournals.com/sanfrancisco/news/2020/05/04/gileads-drug-pricing-in-the-crosshairs-again-in.html+&cd=7&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:QxN148pTFoMJ:https://www.bizjournals.com/sanfrancisco/news/2020/05/04/gileads-drug-pricing-in-the-crosshairs-again-in.html%2B%26cd%3D7%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAGegQIBRAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;" /></li></ol></div></div></div></div><div class="s" style="max-width: 48em; line-height: 1.58;"><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:QxN148pTFoMJ:https://www.bizjournals.com/sanfrancisco/news/2020/05/04/gileads-drug-pricing-in-the-crosshairs-again-in.html+&cd=7&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:QxN148pTFoMJ:https://www.bizjournals.com/sanfrancisco/news/2020/05/04/gileads-drug-pricing-in-the-crosshairs-again-in.html%2B%26cd%3D7%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAGegQIBRAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;"><span class="st" style="line-height: 1.58; overflow-wrap: break-word;"><font size="4" face="Times New Roman" color="#000000"><span class="f" style="line-height: 1.58;">May 4, 2020 -&nbsp;</span>Gilead Sciences Inc. plans to spend $1 billion on its&nbsp;<span style="font-weight: bold;">Covid</span>-19 drug&nbsp;<span style="font-weight: bold;">remdesivir</span>. Now some members of Congress and health care watchdogs&nbsp;...</font></span></a></div></div></div></div></div><div><a class="fl" href="https://webcache.googleusercontent.com/search?q=cache:QxN148pTFoMJ:https://www.bizjournals.com/sanfrancisco/news/2020/05/04/gileads-drug-pricing-in-the-crosshairs-again-in.html+&cd=7&hl=en&ct=clnk&gl=us" ping="/url?sa=t&source=web&rct=j&url=https://webcache.googleusercontent.com/search%3Fq%3Dcache:QxN148pTFoMJ:https://www.bizjournals.com/sanfrancisco/news/2020/05/04/gileads-drug-pricing-in-the-crosshairs-again-in.html%2B%26cd%3D7%26hl%3Den%26ct%3Dclnk%26gl%3Dus&ved=2ahUKEwjwlIur98XpAhUFLqwKHeKkCmwQIDAGegQIBRAG" style="text-decoration-line: none; cursor: pointer; display: block; padding: 7px 18px; outline: 0px;"><font size="4" face="Times New Roman" color="#000000">===</font></a></div></div>